These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9768739

  • 21. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ, Prager NA, Sobel BE, Abendschein DR.
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [Abstract] [Full Text] [Related]

  • 22. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
    Nicolini FA, Nichols WW, Saldeen TG, Mehta JL.
    Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
    [Abstract] [Full Text] [Related]

  • 23. Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography.
    Van Beek EJ, Levi M, Reekers JA, Hack CE, Büller HR, ten Cate JW.
    Radiology; 1994 Dec; 193(3):821-3. PubMed ID: 7972831
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
    Jackson CV, Frank JD, Craft TJ, Sundboom JL, Smith GF.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):64-70. PubMed ID: 1731052
    [Abstract] [Full Text] [Related]

  • 25. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
    Longridge DJ, Follenfant MJ, Ford AJ.
    Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
    [Abstract] [Full Text] [Related]

  • 26. Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets.
    Prager NA, Torr-Brown SR, Sobel BE, Abendschein DR.
    J Am Coll Cardiol; 1993 Jul; 22(1):296-301. PubMed ID: 8509554
    [Abstract] [Full Text] [Related]

  • 27. Role of thrombolysis and thrombin in patients with acute coronary occlusion during percutaneous transluminal coronary angioplasty.
    Gulba DC, Daniel WG, Simon R, Jost S, Barthels M, Amende I, Rafflenbeul W, Lichtlen PR.
    J Am Coll Cardiol; 1990 Sep; 16(3):563-8. PubMed ID: 2117619
    [Abstract] [Full Text] [Related]

  • 28. Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
    Sakariassen KS, Buchmann M, Hamers MJ, Stormorken H.
    Acta Radiol; 1998 Jul; 39(4):355-61. PubMed ID: 9685818
    [Abstract] [Full Text] [Related]

  • 29. Effects of intracoronary administration of contrast media on coronary hemodynamics in a canine post ischemic reperfusion model.
    Sheu SH, Hwang MH, Piao ZE, Hariman RJ, Loeb HS, Scanlon PJ.
    Cathet Cardiovasc Diagn; 1991 Jun; 23(2):144-49. PubMed ID: 2070405
    [Abstract] [Full Text] [Related]

  • 30. Influence of heparin and systemic lysis on coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary thrombosis.
    Martin U, Fischer S, Sponer G.
    J Am Coll Cardiol; 1993 Sep; 22(3):914-20. PubMed ID: 8354832
    [Abstract] [Full Text] [Related]

  • 31. Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
    Lefkovits J, Malycky JL, Rao JS, Hart CE, Plow EF, Topol EJ, Nicolini FA.
    J Am Coll Cardiol; 1996 Dec; 28(7):1858-65. PubMed ID: 8962577
    [Abstract] [Full Text] [Related]

  • 32. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
    Barstad RM, Buchmann MS, Hamers MJ, Orning L, Orvim U, Stormorken H, Sakariassen KS.
    Acta Radiol; 1996 Nov; 37(6):954-61. PubMed ID: 8995473
    [Abstract] [Full Text] [Related]

  • 33. Variation in hemostatic parameters after intra-arterial and intravenous administration of iodinated contrast media.
    Manotti C, Quintavalla R, Ugolotti U, Del Favero C, Dettori AG.
    Invest Radiol; 1992 Dec; 27(12):1025-30. PubMed ID: 1473919
    [Abstract] [Full Text] [Related]

  • 34. Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis.
    Rebello SS, Blank HS, Lucchesi BR.
    Thromb Res; 2000 Jun 15; 98(6):531-40. PubMed ID: 10899352
    [Abstract] [Full Text] [Related]

  • 35. [The effects of angiographic contrast media on the aggregation and morphology of red cells in vitro].
    Higashi S, Yasukochi H, Ishioka K, Toya H, Tanibe M, Koga M, Shirato M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Jun 25; 49(6):748-57. PubMed ID: 2798065
    [Abstract] [Full Text] [Related]

  • 36. Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibition.
    Lynch JJ, Sitko GR, Mellott MJ, Nutt EM, Lehman ED, Friedman PA, Dunwiddie CT, Vlasuk GP.
    Cardiovasc Res; 1994 Jan 25; 28(1):78-85. PubMed ID: 8111795
    [Abstract] [Full Text] [Related]

  • 37. Effect of an ionic compared to a non-ionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterisation.
    Jung F, Spitzer SG, Pindur G.
    Pathophysiol Haemost Thromb; 2002 Jan 25; 32(3):121-6. PubMed ID: 12372925
    [Abstract] [Full Text] [Related]

  • 38. Early intravenous administration of metoprolol enhances myocardial salvage by thrombolysis with recombinant tissue-type plasminogen activator after thrombotic coronary artery occlusion in the dog by improvement of the collateral blood flow to the area at risk.
    Zmudka K, Aubert A, Dubiel J, Vanhaecke J, Flameng W, Kaczmarek J, De Geest H.
    J Am Coll Cardiol; 1994 May 25; 23(6):1499-504. PubMed ID: 8176113
    [Abstract] [Full Text] [Related]

  • 39. Effects of vasoconstrictors on rabbit coronary arteries exposed to isotonic ionic and nonionic contrast media.
    Karstoft J, Bååth L, Jansen I, Edvinsson L.
    Invest Radiol; 1993 Oct 25; 28(10):911-6. PubMed ID: 8262745
    [Abstract] [Full Text] [Related]

  • 40. Prevention of reocclusion following tissue type plasminogen activator-induced thrombolysis by the RGD-containing peptide, echistatin, in a canine model of coronary thrombosis.
    Holahan MA, Mellott MJ, Garsky VM, Shebuski RJ.
    Pharmacology; 1991 Oct 25; 42(6):340-8. PubMed ID: 1946598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.